Expectant Management of Severe Preeclampsia Remote from Term: A Structured Systematic Review

REFERENCES

• Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994; 84: 626–30
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070–1075
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818–822
   PubMed Web of Science ®Google Scholar
• Churchill D, Duley L. Interventionist versus expectant care for severe preeclampsia before term. Cochrane Database Syst Rev 2002; CD003106
   Google Scholar
• Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332–1336
   PubMed Web of Science ®Google Scholar
• www.ohri.ca/programs/clinical_epidemiology/oxford.htm, Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
   Google Scholar
• Bolte AC, van Eyck J, Gaffar SF, van Geijn HP, Dekker GA. Ketanserin for the treatment of preeclampsia. J Perinat Med 2001; 29: 14–22
   PubMed Web of Science ®Google Scholar
• Budden A, Wilkinson L, Buksh MJ, McCowan L. Pregnancy outcome in women presenting with preeclampsia at less than 25 weeks gestation. Aust NZ J Obstet Gynaecol 2006; 46: 407–412
   PubMed Web of Science ®Google Scholar
• de Boer K, Buller HR, ten Cate JW, Treffers PE. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol 1991; 98: 42–47
   PubMedGoogle Scholar
• Derham RJ, Hawkins DF, De Vries LS, Aber VR, Elder MG. Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors. Br J Obstet Gynaecol 1989; 96: 1173–1181
   PubMedGoogle Scholar
• Dreyfus M, Tissier I, Ndocko MA, Denoual I, Baldauf JJ, Ritter J. Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1999; 85: 233–234
   PubMed Web of Science ®Google Scholar
• Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991; 77: 331–337
   PubMed Web of Science ®Google Scholar
• Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 1995; 172: 1785–1788
   PubMed Web of Science ®Google Scholar
• Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or = 28.0 weeks' gestation. Am J Obstet Gynecol 2000; 183: 1475–1479
   PubMed Web of Science ®Google Scholar
• Harms K, Rath W, Herting E, Kuhn W. Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. Am J Perinatol 1995; 12: 1–6
   PubMed Web of Science ®Google Scholar
• Hjertberg R, Belfrage P, Hagnevik K. Hemodynamic measurements with Swan-Ganz catheter in women with severe proteinuric gestational hypertension (preeclampsia). Acta Obstet Gynecol Scand 1991; 70: 193–198
   PubMed Web of Science ®Google Scholar
• Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN, Jr. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001; 184: 1332–1337
   PubMed Web of Science ®Google Scholar
• Izquierdo LA, Gilson GJ, Urquhart ST, Gardner MO, Rappaport VM, Curet LB. Analysis of expectant versus active management of in patients with severe preeclampsia between 24 and 34 weeks of gestational age. Prenat Neonat Med 1998; 3: 323–326
   Google Scholar
• Jenkins SM, Head BB, Hauth JC. Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes. Am J Obstet Gynecol 2002; 186: 790–795
   PubMed Web of Science ®Google Scholar
• Kirsten GF, Van Zyl JI, Van Zijl F, Maritz JS, Odendaal HJ. Infants of women with severe early preeclampsia: the effect of absent end-diastolic umbilical artery doppler flow velocities on neurodevelopmental outcome. Acta Paediatr 2000; 89: 566–570
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Terao T, Ikenoue T, Sameshima H, Nakabayashi M, Kajiwara Y, et al. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Semin Thromb Hemost 2003; 29: 645–652
   PubMed Web of Science ®Google Scholar
• Magann EF, Martin RW, Isaacs JD, Blake PG, Morrison JC, Martin JN, Jr. Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome. Aust NZ J Obstet Gynaecol 1993; 33: 127–131
   PubMed Web of Science ®Google Scholar
• Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN, Jr. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171: 1148–1153
   PubMed Web of Science ®Google Scholar
• O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 921–924
   PubMed Web of Science ®Google Scholar
• O'Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002; 186: 475–479
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Hall DR, Grove D. Risk factors for and perinatal mortality of abruptio placentae in patients hospitalised for early onset severe preeclampsia – a case controlled study. J Obstet Gynaecol 2000; 20: 358–364
   PubMedGoogle Scholar
• Roes EM, Raijmakers MT, Boo TM, Zusterzeel PL, Merkus HM, Peters WH, et al. Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 127: 61–67
   PubMed Web of Science ®Google Scholar
• Ruvinsky ED, Douvas SG, Roberts WE, Martin JN, Jr., Palmer SM, Rhodes PG, et al. Maternal administration of dexamethasone in severe pregnancy-induced hypertension. Am J Obstet Gynecol 1984; 149: 722–726
   PubMed Web of Science ®Google Scholar
• Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987; 70: 323–327
   PubMed Web of Science ®Google Scholar
• Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999; 181: 304–309
   PubMed Web of Science ®Google Scholar
• van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 2000; 19: 211–220
   PubMed Web of Science ®Google Scholar
• Wide-Swensson D, Montan S, Arulkumaran S, Ingemarsson I, Ratnam SS. Effect of methyldopa and isradipine on fetal heart rate pattern assessed by computerized cardiotocography in human pregnancy. Am J Obstet Gynecol 1993; 169: 1581–1585
   PubMed Web of Science ®Google Scholar
• Rose CH, Thigpen BD, Bofill JA, Cushman J, May WL, Martin JN, Jr. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol 2004; 104: 1011–1014
   PubMed Web of Science ®Google Scholar
• Runnard Heimel PJ, Huisjes AJ, Franx A, Koopman C, Bots ML, Bruinse HW. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 2006; 128: 187–193
   PubMed Web of Science ®Google Scholar
• Banias BB, Devoe LD, Nolan TE. Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation. Am J Perinatol 1992; 9: 357–360
   PubMed Web of Science ®Google Scholar
• Begum MR, Akhter S, Begum A, Khatun M, Quadir E, Choudhury SB. Conservative management of eclampsia and severe preeclampsia—A Bangladesh experience. Medscape Womens Health 2002; 7: 1
   Google Scholar
• Blackwell SC, Redman ME, Tomlinson M, Berry SM, Sorokin Y, Cotton DB. Severe preeclampsia remote from term: what to expect of expectant management. J Matern Fetal Neonatal Med 2002; 11: 321–324
   PubMedGoogle Scholar
• Chammas MF, Nguyen TM, Li MA, Nuwayhid BS, Castro LC. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 2000; 183: 853–858
   PubMed Web of Science ®Google Scholar
• Chari RS, Friedman SA, O'Brien JM, Sibai BM. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol 1995; 173: 1207–1210
   PubMed Web of Science ®Google Scholar
• Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996; 175: 1313–1316
   PubMed Web of Science ®Google Scholar
• Schucker JL, Mercer BM, Audibert F, Lewis RL, Friedman SA, Sibai BM. Serial amniotic fluid index in severe preeclampsia: a poor predictor of adverse outcome. Am J Obstet Gynecol 1996; 175: 1018–1023
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, Bonsel GJ, Fetter WP, van Sonderen L, De Vries JI, et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset preeclampsia. BJOG 2005; 112: 1358–1368
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, Bonsel GJ, De Vries JI, Wolf H. A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery. Am J Obstet Gynecol 2005; 192: 233–239
   PubMed Web of Science ®Google Scholar
• Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Siba BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190: 1590–1595
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grove D. Expectant management of early onset, severe preeclampsia: perinatal outcome. BJOG 2000; 107: 1258–1264
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe preeclampsia: maternal outcome. BJOG 2000; 107: 1252–1257
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Steyn DW. Delivery of patients with early onset, severe preeclampsia. Int J Gynaecol Obstet 2001; 74: 143–150
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Steyn DW. Expectant management of severe preeclampsia in the mid-trimester. Eur J Obstet Gynecol Reprod Biol 2001; 96: 168–172
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Steyn DW, Grove D. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynaecol Obstet 2002; 77: 1–6
   PubMed Web of Science ®Google Scholar
• Hall DR, Grove D, Carstens E. Early preeclampsia: what proportion of women qualify for expectant management and if not, why not?. Eur J Obstet Gynecol Reprod Biol 2006; 128: 169–174
   PubMed Web of Science ®Google Scholar
• Hanff LM, Vulto AG, Bartels PA, Roofthooft DW, Bijvank BN, Steegers EA, et al. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset preeclamptic patients. J Hypertens 2005; 23: 2319–2326
   PubMed Web of Science ®Google Scholar
• Moodley J, Koranteng SA, Rout C. Expectant management of early onset of severe preeclampsia in Durban. S Afr Med J 1993; 83: 584–587
   PubMed Web of Science ®Google Scholar
• Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19: 221–231
   PubMed Web of Science ®Google Scholar
• Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol 2003; 188: 264–268
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, du TR. Fetal and neonatal outcome in patients with severe preeclampsia before 34 weeks. S Afr Med J 1987; 71: 555–558
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, du TR, Grove D. Frequent fetal heart-rate monitoring for early detection of abruptio placentae in severe proteinuric hypertension. S Afr Med J 1988; 74: 19–21
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Steyn DW, Norman K, Kirsten GF, Smith J, Theron GB. Improved perinatal mortality rates in 1001 patients with severe preeclampsia. S Afr Med J 1995; 85: 1071–1076
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pienaar ME. Are high uric acid levels in patients with early preeclampsia an indication for delivery?. S Afr Med J 1997; 87: 213–218
   PubMedGoogle Scholar
• Pattinson RC, Odendaal HJ, du TR. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J 1988; 73: 516–518
   PubMed Web of Science ®Google Scholar
• Oettle C, Hall D, Roux A, Grove D. Early onset severe preeclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG 2005; 112: 84–88
   PubMed Web of Science ®Google Scholar
• Olah KS, Redman CW, Gee H. Management of severe, early preeclampsia: is conservative management justified?. Eur J Obstet Gynecol Reprod Biol 1993; 51: 175–180
   PubMed Web of Science ®Google Scholar
• Onah HE, Iloabachie GC. Conservative management of early-onset preeclampsia and fetomaternal outcome in Nigerians. J Obstet Gynaecol 2002; 22: 357–362
   PubMedGoogle Scholar
• Railton A, Allen DG. Management and outcome of pregnancy complicated by severe preeclampsia of early onset. S Afr Med J 1987; 72: 608–610
   PubMed Web of Science ®Google Scholar
• Shear RM, Rinfret D, Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?. Am J Obstet Gynecol 2005; 192: 1119–1125
   PubMed Web of Science ®Google Scholar
• Spinillo A, Iasci A, Capuzzo E, Egbe TO, Colonna L, Fazzi E. Two-year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies. Acta Obstet Gynecol Scand 1994; 73: 625–629
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Montufar-Rueda C, Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 2003; 107: 24–27
   PubMed Web of Science ®Google Scholar
• Visser W, van Pampus MG, Treffers PE, Wallenburg HC. Perinatal results of hemodynamic and conservative temporizing treatment in severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 1994; 53: 175–181
   PubMed Web of Science ®Google Scholar
• Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995; 63: 147–154
   PubMed Web of Science ®Google Scholar
• Withagen MI, Visser W, Wallenburg HC. Neonatal outcome of temporizing treatment in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 94: 211–215
   PubMed Web of Science ®Google Scholar
• Withagen MI, Wallenburg HC, Steegers EA, Hop WC, Visser W. Morbidity and development in childhood of infants born after temporising treatment of early onset preeclampsia. BJOG 2005; 112: 910–914
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, Bonsel GJ, De Vries JI, Wolf H. Dynamics and incidence patterns of maternal complications in early-onset hypertension of pregnancy. BJOG 2007; 114: 741–750
   PubMed Web of Science ®Google Scholar
• Visser W, Wallenburg HC. Temporising management of severe preeclampsia with and without the HELLP syndrome. Br. J Obstet Gynaecol. 1995; 102: 111–117
   PubMedGoogle Scholar
• Gaugler-Senden IP, Huijssoon AG, Visser W, Steegers EA, de Groot CJ. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 2006; 128: 216–221
   PubMed Web of Science ®Google Scholar
• Sibai BM, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990; 163: 733–738
   PubMed Web of Science ®Google Scholar
• Chua S, Redman CW. Prognosis for preeclampsia complicated by 5 g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol 1992; 43: 9–12
   PubMed Web of Science ®Google Scholar
• Haddad B, Kayem G, Deis S, Sibai BM. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?. Am J Obstet Gynecol 2007; 196: 237–235
   PubMed Web of Science ®Google Scholar
• Haddad B, Cabrol D, Cynober E, Paniel BJ. Severe uterine diastolic notch as a prognostic factor in preeclamptic women. Eur J Obstet Gynecol Reprod Biol 1999; 85: 179–183
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006; 195: 495–503
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070–1075
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818–822
   PubMed Web of Science ®Google Scholar
• Menzies J, Magee LA, Li J, Macnab YC, Yin R, Stuart H, et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007; 110: 121–127
   PubMed Web of Science ®Google Scholar